These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 30212688)
1. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy. Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688 [TBL] [Abstract][Full Text] [Related]
2. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981 [TBL] [Abstract][Full Text] [Related]
3. Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth. Wu P; Liu Q; Wang Q; Qian H; Yu L; Liu B; Li R Int J Nanomedicine; 2018; 13():5405-5418. PubMed ID: 30271137 [TBL] [Abstract][Full Text] [Related]
4. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123 [TBL] [Abstract][Full Text] [Related]
5. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer. Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911 [TBL] [Abstract][Full Text] [Related]
6. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055 [No Abstract] [Full Text] [Related]
7. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390 [TBL] [Abstract][Full Text] [Related]
8. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer. Sharma R; Yadav V; Jha S; Dighe S; Jain S Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723 [TBL] [Abstract][Full Text] [Related]
9. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586 [TBL] [Abstract][Full Text] [Related]
11. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles. Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706 [TBL] [Abstract][Full Text] [Related]
12. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697 [TBL] [Abstract][Full Text] [Related]
13. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo. Wang W; Xi M; Duan X; Wang Y; Kong F Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664 [TBL] [Abstract][Full Text] [Related]
14. Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells. Zeng YB; Yu ZC; He YN; Zhang T; Du LB; Dong YM; Chen HW; Zhang YY; Wang WQ Acta Pharmacol Sin; 2018 Feb; 39(2):261-274. PubMed ID: 29388568 [TBL] [Abstract][Full Text] [Related]
15. Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells. Li L; Cui D; Ye L; Li Y; Zhu L; Yang L; Bai B; Nie Z; Gao J; Cao Y Anticancer Drugs; 2017 Oct; 28(9):989-1001. PubMed ID: 28692437 [TBL] [Abstract][Full Text] [Related]
16. Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel. Wang B; Hu W; Yan H; Chen G; Zhang Y; Mao J; Wang L Biomed Pharmacother; 2021 Apr; 136():111249. PubMed ID: 33450493 [TBL] [Abstract][Full Text] [Related]
17. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. Wu J; Zhang J; Deng C; Meng F; Zhong Z Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935 [TBL] [Abstract][Full Text] [Related]
18. Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458 [TBL] [Abstract][Full Text] [Related]
19. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells. Yao HJ; Zhang YG; Sun L; Liu Y Biomaterials; 2014 Nov; 35(33):9208-23. PubMed ID: 25115788 [TBL] [Abstract][Full Text] [Related]
20. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]